Research ArticleArticle
Repressive Epigenetic Changes at the mGlu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice
Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B. Hanks, Rachael Neve, Eric J. Nestler, Scott J. Russo and Javier González-Maeso
Molecular Pharmacology June 2013, 83 (6) 1166-1175; DOI: https://doi.org/10.1124/mol.112.084582
Mitsumasa Kurita
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
José L. Moreno
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Terrell Holloway
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Alexey Kozlenkov
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Giuseppe Mocci
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Aintzane García-Bea
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
James B. Hanks
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Rachael Neve
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Eric J. Nestler
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Scott J. Russo
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
Javier González-Maeso
Departments of Psychiatry (M.K., J.L.M., T.H., A.K., G.M., A.G.B., J.B.H., E.J.N., J.G.M.), Neurology (J.G.M.), Neuroscience (E.J.N., S.J.C.), Pharmacology and Systems Therapeutics (E.J.N.), and Friedman Brain Institute (E.J.N., S.J.R., J.G.M.), Icahn School of Medicine at Mount Sinai, New York, New York; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts (R.N.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Epigenetic Changes at mGlu2 in 5-HT2A-KO Mice
Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B. Hanks, Rachael Neve, Eric J. Nestler, Scott J. Russo and Javier González-Maeso
Molecular Pharmacology June 1, 2013, 83 (6) 1166-1175; DOI: https://doi.org/10.1124/mol.112.084582
Research ArticleArticle
Epigenetic Changes at mGlu2 in 5-HT2A-KO Mice
Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B. Hanks, Rachael Neve, Eric J. Nestler, Scott J. Russo and Javier González-Maeso
Molecular Pharmacology June 1, 2013, 83 (6) 1166-1175; DOI: https://doi.org/10.1124/mol.112.084582
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement